SHP Wealth Management
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1807060
PLYMOUTH, MA
Position in TEVA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$4,909
-$490 QoQ
Shares Held
163
-5.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SHP Wealth Management holds $184,971 across 18 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
3,158 | $65,560 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,537 | $46,985 | |
| 3 | ZTS |
Zoetis Inc.
|
143 | $16,904 | |
| 4 | RMTI |
Rockwell Medical, Inc.
|
1,421 | $12,646 | |
| 5 | HLN |
Haleon plc
|
1,011 | $10,120 | |
| 6 | ANIK |
Anika Therapeutics, Inc.
|
681 | $9,874 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
504 | $6,980 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
163 | $4,909 |
All Filings in TEVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,909 | 163 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $5,399 | 173 | Shares | Sole | 2026-03-04 | |
| No filing history on record for this holder in this stock. | ||||||